Cart
sales@molnova.com
DCLX069
CAS No. 792946-69-1
DCLX069( DCLX-069 | DCLX 069 )
Catalog No. M27868 CAS No. 792946-69-1
DCLX069 is a selective protein arginine methyltransferase 1 (PRMT1) inhibitor with an IC50 value of 17.9 μM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 41 | Get Quote |
|
| 5MG | 65 | Get Quote |
|
| 10MG | 102 | Get Quote |
|
| 25MG | 176 | Get Quote |
|
| 50MG | 290 | Get Quote |
|
| 100MG | 462 | Get Quote |
|
| 500MG | 981 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameDCLX069
-
NoteResearch use only, not for human use.
-
Brief DescriptionDCLX069 is a selective protein arginine methyltransferase 1 (PRMT1) inhibitor with an IC50 value of 17.9 μM.
-
DescriptionDCLX069 is a selective protein arginine methyltransferase 1 (PRMT1) inhibitor with an IC50 value of 17.9 μM. DCLX069 occupies the SAM binding pocket to exert the inhibitory effect. DCLX069 effectively blocks cell proliferation in breast cancer, liver cancer, and acute myeloid leukemia cell lines.
-
In Vitro——
-
In Vivo——
-
SynonymsDCLX-069 | DCLX 069
-
PathwayChromatin/Epigenetic
-
TargetHistone Demethylase
-
RecptorDNA alkylator
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number792946-69-1
-
Formula Weight339.44
-
Molecular FormulaC20H25N3O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (294.61 mM)
-
SMILESO=C(OCC)C1=CC=C(N2CCN(CC3=CC=CC=C3)CC2)C(N)=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.D T Beranek. Distribution of methyl and ethyl adducts following alkylation with monofunctional alkylating agents. Mutat Res. 1990 Jul;231(1):11-30.
molnova catalog
related products
-
SD49-7
SD49-7 is an inhibitor of histone lysine demethylase 4 (KDM4) with an IC50 of 0.19 μM.
-
PFI-90
PFI-90 is a selective inhibitor of histone demethylase (KDM3B) that inhibits PAX3-FOXO1 action.PFI-90 has the potential for the antitumor activity.
-
M?89
M-89 inhibits the menin-mixed lineage leukemia (Menin-MLL) protein-protein interaction and has potential to treat MLL leukemia.?M-89 is a highly potent and specific menin inhibitor, with a Kd of 1.4 nM for binding to menin.
